Targeting Adenosine for Cancer:Challenging Past Assumptions with Next-Generation Small Molecule Inhibitors Thursday, March 9th @ 10:30 am ET WESTPORT, Conn., Feb. 27, 2023 Portage Biotech Inc.. | February 27, 2023
Portage Biotech Issues Letter to Shareholders WESTPORT, Conn., Aug. 12, 2021 Portage Biotech Inc., a clinical-stage immuno-oncology company focused on the development of. | August 13, 2021